Aim: Diagnosing individuals at ultra high risk (UHR) for psychosis can improve early access to treatment, and a two-stage model utilizing self-report screening followed by a clinical interview can be accurate and efficient. However, it is currently unclear which screening cut-offs to adopt with different populations.
Vinogradov, Bearden, & Cannon, 2011) . The advantages of adopting such tools were outlined by Rietdijk and colleagues, who found that using the PQ in secondary mental healthcare services resulted in a 3-fold increase in detection of UHR, relative to standard referral methods .
Although the PQ (Loewy et al., 2005) , PRIME (Miller et al., 2004) and YPARQ-B (Ord et al., 2004) have all been found to be valid assessment tools for UHR (Kline et al., 2012) , in a recent review, the PQ has been found to be the most commonly used instrument in the literature ) and so will be the focus of this investigation. The evidence suggests that although the PQ is successful at identifying UHR individuals in various settings (ie Ising et al., 2012) , there is no consensus on what the appropriate cut-off scores should be for screening in these different contexts. It is unlikely that a "one-size fits all" approach would be appropriate due to issues relating to spectrum bias resulting from differences in the case mix of participants between different settings (Willis, 2008) . Determining appropriate cut-off points is further complicated by the existence of 3 different iterations of the PQ scale, the PQ-92 (Loewy et al., 2005) , the PQ-16 and the PQ-B (Loewy et al., 2011) , of which each can be scored differently.
In this study, a systematic review of all diagnostic accuracy studies that assess the effectiveness of screening for UHR and psychosis with the PQ was completed, with the aim of producing guidelines specifying what cut-off points should be adopted in different populations. In the second part of the study, a systematic review of studies using the PQ as a screening tool without formal evaluation against a gold-standard interview was completed in order to assess the congruency between the research recommendations and current practice.
| METHODS

| Protocol registration
The study protocol is available on the PROSPERO database (ID: CRD42016033004).
| Search strategy
An electronic search of SCOPUS, PsycInfo, PubMed and ProQuest Dissertation and Abstracts databases was conducted on January 3, 2017, using 2 parameters. The first included terms defining the UHR state, including "prodrome," "prodromal," "clinical high risk," "ultra high risk," "attenuated psychotic," "attenuated psychosis" and "attenuated positive." The second parameter related to the Prodromal Questionnaire, including "PQ," "PQ-92," "PQ-16" and "PQ-B." An additional single search term, ,"Prodromal Questionnaire" was also included, which resulted in the article being identified regardless of the previous search. The time period of the search started from January 1, 2005 when the original PQ was first published (Loewy et al., 2005) . A screening of all studies that referenced one of the original papers outlining the 3 different versions of the PQ was completed Loewy et al., 2005 Loewy et al., , 2011 , identified using Google Scholar. Finally, the reference list of all systematic reviews related specifically to UHR screening tools was hand-searched.
During extraction, details regarding participant demographics, study methodology, screening cut-offs and diagnostic accuracy statistics were recorded on a piloted extraction sheet. Corresponding authors were contacted for more information where necessary. L.) was assigned to adjudicate in cases of disagreement.
| Eligibility criteria
In the initial screening case reports, qualitative studies, non-human studies and those not using the PQ were excluded. In the fullmanuscript screening phase, studies where the PQ was not used to screen for UHR or where cut-offs were not reported were excluded.
Of this sample, studies that compared the diagnostic accuracy of the PQ to either the SIPS (Miller et al., 2003) or the Comprehensive Assessment of the At-Risk Mental States (CAARMS; Yung et al., 2005) were then selected for the diagnostic accuracy review. Given that the PQ is not designed to make a distinction between UHR and full psychosis (see Loewy et al., 2005) but rather to determine whether individuals are experiencing at least attenuated psychotic symptoms to a level where a more thorough evaluation is necessary, participants diagnosed as experiencing full psychosis by either the CAARMS or the SIPS were included in the UHR-positive category. In cases where the same diagnostic accuracy data were presented in different articles, only the most relevant was retained, with any missing data filled in from the excluded studies. In order to include as broad a pool of studies as possible, grey literature and studies published in any language were considered eligible.
| Assessment tools
The original PQ (Loewy et al., 2005) comprises of 92 yes/no items, including 45 positive, 19 negative, 13 disorganized and 15 general symptom items. Screening can be completed using either all 92 items or the positive symptom subscale alone. In a later version (Loewy, Johnson, & Cannon, 2007) , the questionnaire was extended to assess whether symptoms experienced were considered distressing. In this version, a cut-off specifying the number of positive symptoms considered distressing can be used. The PQ-92 scale has not been published previously. Therefore, the full measure-with the distress criteria and scoring instructions-has been included in the supporting material (see Appendix S1).
In order to improve the efficiency and accuracy of UHR identification, 2 shorter versions of the PQ scale have been produced: the PQ-16 and the PQ-B (Loewy et al., 2011) . The PQ-16 comprises of 16 items, assessed over the responders' lifetime. Nine items cover perceptual abnormalities, 5 unusual thought content and paranoia and 2 negative symptoms.
Each item is marked true/false, with endorsed symptoms rated on a scale of distress ranging from 0 (no distress) to 3 (severe). The PQ-16
can be scored by a sum of the distress scores (range 0-48) or the total number of symptoms endorsed (range 0-16). The PQ-B comprises of 21 items, recording positive symptoms experienced over the past month. For each endorsed symptom, responders rate whether they found it distressing or impairing, ranging from 1 (strongly disagree) to 5 (strongly agree), with a 4 or 5 indicating distress. The PQ-B has been adopted as a screening tool using the total number of items endorsed, the number of items that are identified as distressing (both range 0-21) and the total distress score (range 0-105), with the latter method recommended by Loewy and colleagues.
Although the scales have been found to successfully identify potential UHR cases based on the presence of attenuated psychotic symptoms, it is important to note that these instruments do not record family history and the presence of schizotypal personality disorder nor are they able to determine recent functional decline. As a result, although these scales can detect the attenuated positive state (APS) and brief intermittent psychotic state (BIPS) categories that form part of the UHR syndrome, the genetic risk and deterioration syndrome (GRDS)-without the additional presence of attenuated symptoms-is unlikely to be identified.
| Assessment of bias
An assessment of bias was based on a modified version of the QUA-DAS (Whiting et al., 2003) . Studies were evaluated on 8 criteria:
issues with the participant selection procedure; gold standard selection and execution; the risk of progression, partial or differential verification bias; whether assessors were blinded to the PQ scores; and whether participant withdrawals were accounted for.
| Analysis plan
Owing to anticipated study heterogeneity and with the SIPS and CAARMS assessments using slightly different criteria to determine UHR status, a meta-analysis of diagnostic test accuracy was not considered feasible. In addition, summary statistics of diagnostic accuracy (presented here as diagnostic odds ratios; DOR) were not compared between studies given that differences in study design (eg sample selection, outcome measurement, method of analysis) were expected to significantly influence the values reported. Instead, a narrative synthesis outlining trends was reported based on the optimum sensitivity, specificity and DOR values at each PQ threshold score within each study. The DOR was selected as the principle measure of diagnostic test effectiveness due to its single value and independence to prevalence, unlike alternatives such as the positive and negative predictive values, which are likely to be very different between the different studies.
As with any diagnostic tool, adopting a cut-off point is a balancing act between selecting a level sufficiently sensitive to identify an appropriate proportion of cases but stringent enough in order to minimize the number of false positives. In the original validation study (Loewy et al., 2005) , it was proposed that when screening for UHR to identify those eligible for research or specialist evaluation, it is usually important to select a symptom cut-off point that prioritizes sensitivity over specificity to minimize the risk of missing UHR individuals. However, to what extent sensitivity should be prioritized over specificity using this tool is largely dependent on the context in which it is being used, and at present, no guidelines exist suggesting what levels may be considered appropriate. In the field of developmental disorder screening, a sensitivity and specificity of at least 70% to 80% has been suggested, which is lower than many other areas of medicine in recognition of the complexities of measurement (Barnes, 1982) .
Given that measuring and diagnosing sub-threshold psychotic states is also considered a highly complex undertaking (McGorry, Yung, & Phillips, 2003) , we considered adopting a similar appropriate threshold . Therefore, in studies where multiple clinical cut-offs are presented, the one that provides the highest diagnostic odds ratio with a sensitivity of at least 75% was presented. Owing to anticipated study heterogeneity, a higher DOR was not considered indicative of a more accurate assessment, relative to other studies.
| RESULTS
| Summary of articles
A total of 14 diagnostic accuracy studies and 45 studies using the PQ as a screening tool for UHR were identified (see Figure 1) , with all eligible studies presented in Table 1 . Two diagnostic accuracy studies used the PQ-92, 3 used the PQ-16, 8 used the PQ-B, and one used both the PQ-16 and the PQ-92. Six studies were completed in the United States; 3 in China; and each one in Australia, Finland, the Netherlands, Nigeria and the United Kingdom.
For the purposes of analysis, the diagnostic accuracy studies were grouped together into 4 different categories: non-help-seeking populations (typically student samples), populations seeking help for non-specific mental health concerns recruited in secondary mental health-care settings, referrals to early intervention services or prodromal clinics (defined as UHR-/psychosis-enriched populations) and prison populations.
| Optimum cut-off points for the PQ
The optimum cut-off points and their accompanying sensitivity, specificity and diagnostic accuracy statistics are presented in Table 2 . In all 14 studies, the PQ was found to be an accurate predictor of UHR diagnosis, with area under the curve (AUC) estimates ranging from 0.71 (95% CI 0.57-0.85) to 0.95 (95% CI 0.94-0.95).
| The PQ-92
Three studies reporting data on the diagnostic accuracy of the PQ-92 were identified. In a general mental health setting, a positive subscale cut-off of ≥18 was supported by 2 studies. In a UHR-and psychosisenriched sample, the positive subscale was found to be more accurate than the total PQ-92 score, with a cut-off of ≥8 positive symptoms recommended. No eligible studies evaluating the diagnostic accuracy of the PQ-92 in non-help-seeking populations were identified.
| The PQ-16
Four studies reporting data on the diagnostic accuracy of PQ -16 were identified. In a non-help-seeking population, a total distress score threshold of ≥9 was supported, and in general mental health help-seeking populations, a lower distress score cut-off of ≥8 was supported, along with symptom scores of ≥6 and ≥5, respectively.
| The PQ-B
Eight diagnostic accuracy studies using the PQ-B were identified. Of these, 3 evaluated the number of distressing symptoms endorsed. In a non-help-seeking population, a threshold of ≥8 distressing items was proposed, far higher than the ≥4 distressing items found to be most appropriate in a UHR-enriched sample. In a prison population, a cut-off of value of ≥2 distressing symptoms resulted in the highest DOR; however, ≥7 distressing symptoms produced a balance between sensitivity and specificity that was more appropriate for UHR screening, Six studies evaluated the total distress score for screening, of which 4 were completed in UHR-/psychosis-enriched samples. In samples with a very high prevalence of UHR/psychosis patients (86.5%), a total distress score of ≥6 was supported, whereas in similar settings with a much lower prevalence (~40%), a distress score of ≥18 was recommended. In a general mental health help-seeking population, a total distress score of ≥24 was found to result in a balance between sensitivity and specificity that was appropriate for screening.
Four studies adopted the total number of symptoms endorsed, of which 2 were completed in UHR-/psychosis-enriched samples. In a sample with a very high proportion of UHR and psychotic participants (86.5%), a cut-off score of ≥3 symptoms was supported, whereas in a lower prevalence sample from a similar setting, a higher threshold of ≥9 symptoms endorsed (albeit below the 75% sensitivity threshold). In a general mental health help-seeking population, a clinical cut-off of ≥7 was supported. In prison populations, a cut-off of ≥5 was proposed; however, this cut-off resulted in very high specificity and low specificity (sensitivity = 98%, specificity = 24%).
| Distress vs number of symptoms
Six studies reported the diagnostic accuracy of the PQ using both the number of symptoms endorsed as a cut-off and a distress score (either the total distress score or the number of distressing items). In two studies, the AUC was larger when the distress score was adopted, relative to the number of symptoms endorsed . In the 4 other studies, the specificity was higher when distress was adopted in 3 of the studies, (Loewy et al., 2011: 68% com- pared to 58%; Jarrett et al., 2012: 62% compared to 24%; Xu et al., 2016 64% compared to 60%), whilst in the fourth , this could not be determined due to insufficient data.
These findings suggest that incorporating a measure of distress may be a more appropriate method for UHR screening, particularly when minimizing the volume of false positives is an important consideration.
| Summary of cut-offs adopted in the literature
A summary of the non-diagnostic accuracy studies that used the PQ as a screening tool is presented in Table 1 . A total of 27 studies used the PQ-92 as a screening tool, primarily in non-help-seeking or general mental health help-seeking populations. A threshold of ≥18 positive symptoms was adopted in 15 studies; 9 studies used a threshold of ≥8 distressing positive symptoms, and 4 used a threshold of ≥8 positive symptoms, not considering distress. The ≥18 positive symptom threshold was primarily adopted in general mental health help-seeking samples, whereas the threshold of ≥8 distressing symptoms was most commonly used in non-help-seeking populations. In the PQ-16, a distress score threshold of ≥6 score was consistently adopted, both in non-help-seeking samples and those recruited in general mental health settings (5 of 7 articles). Seven studies used the PQ-B as a screening tool. In the studies completed in non-help-seeking populations, one used a cut-off of one symptom being scored a "4" or higher on the distress scale, one a score of "5" on 1 item, one ≥8 distressing symptoms and one a threshold of both ≥6 symptoms and a distress total score of ≥29. In two studies completed in a general mental health help-seeking population, both studies used a cut-off of either ≥3 symptoms endorsed or a distress score of ≥6. In one study completed in a prison setting, a cut-off of ≥5 symptoms was adopted.
| Bias assessment
An assessment of study bias is presented in the supporting material ( Figure S1 ). In most parameters, the majority of studies were reported in a manner that suggested there was a low risk of bias. However, the majority of studies (92.3%) did not report whether the interviewer who conducted the SIPS/CAARMS assessment was blinded to the screening score, and in 5 studies, a non-random selection of participants was followed up with the reference standard, including all those who scored above a pre-specified PQ threshold but only a selection of those who scored below. This can lead to partial verification bias, which can inflate sensitivity at the expense of specificity (Zhou, 1998) .
| DISCUSSION
| Main results
Over all populations examined, the PQ was found to be an accurate screening tool to identify possible UHR cases. In addition, there is some evidence to suggest that incorporating distress may improve the accuracy of screening by minimizing false positives. Higher screening cut-offs appear to be required in non-help-seeking samples, relative to general mental health samples, which are in turn higher than those required in highly enriched populations. This is important given that the current thresholds adopted in the literature appear to be the same regardless of population characteristics and are often based on diagnostic accuracy studies completed in more enriched samples.
| Recommendations
These recommendations (summarized below and in Table 3 ) should be considered only general guidelines and come with a number of caveats. First, these recommendations are based on relatively few studies and so are likely to be revised as more studies in the field are completed; in fact, our primary recommendation is that future research attempt to replicate the same cut-offs to establish reliability.
Second, it is unclear what thresholds to adopt in alternative settings, such as primary care, which may be an important avenue for the early identification of psychosis (Cole, Leavey, King, Johnson-Sabine, & Hoar, 1995) . Third, given the significant heterogeneity between studies that used different iterations of the PQ, these findings cannot provide firm recommendations on which particular scale to use in each setting. That said, given that all 3 were consistently found to be an appropriate screening tool for UHR, the PQ-16 or the PQ-B may be considered preferable over the PQ-92 due to brevity. Fourth, it is important to note that all 3 iterations of the scale do not measure family history and presence of schizotypal personality disorder but do measure rate of functional decline. As a result, these scales are unlikely to identify those with GRDS, and so, additional information is necessary to identify this particular subgroup of UHR patients to ensure that they are not incorrectly excluded from any screening programme. Fifth, the thresholds recommended are based on the premise that a sensitivity of at least 75% is appropriate for preliminary UHR screening, whereas a different balance between sensitivity and specificity may be more appropriate depending on the context.
One example of this may be where a service may anticipate only a small number of referrals but have the capacity for a large number of assessments, meaning a lower threshold may be appropriate to maximize UHR detection. In such cases, piloting a lower cut-off point would be recommended. Alternatively, a higher specificity may be preferable with limited resources for the evaluation of a large screened population, meaning a higher cut-off point should be tested in order to focus on those most likely to be true positives.
| The PQ-92
The positive symptom subscale may be more appropriate for UHR screening relative to the whole instrument. Evidence supports a threshold of ≥8 positive symptoms in highly enriched samples and ≥18 positive symptoms in general mental health help-seeking populations. No evidence of an appropriate cut-off point to adopt in nonhelp-seeking populations was identified. However, if the scale is adopted in this setting, then a cut-off score of at least ≥18 positive symptoms would be recommended.
| The PQ-16
Using the distress scale, rather than the total symptom score, may improve the accuracy of the scale. In non-help-seeking settings, a distress score of ≥9 appears appropriate. In general mental health helpseeking populations, a threshold of ≥8 was supported; however, the very high specificity at this level suggests that slightly lower thresholds may also be appropriate. When using the symptom score, a threshold of ≥5 to 6 appears appropriate in general mental health settings. No appropriate thresholds were identified in highly enriched samples, so careful piloting of any thresholds adopted in this setting would be recommended.
| The PQ-B
In non-help-seeking populations, a threshold of ≥8 symptoms reported as distressing has been supported. In general mental health settings, either a total distress score of ≥24 or a symptom total score of ≥7 was found to be both suitably sensitive and specific. In most UHR-/psychosis-enriched samples, a total distress score of ≥18 would be recommended; however, in populations anticipated to have a high prevalence of UHR/psychotic patients, a lower total distress score may be appropriate (ie ≥6).
| Strengths and limitations
One strength of the study is the consistency of the findings. All identified studies supported the accuracy of the PQ as a screening tool, and in all 3 iterations of the scale, higher cut-offs were required in settings with a lower prevalence of UHR. The search identified a larger number of studies than anticipated and included a number of non-English and grey literature studies, increasing the generalizability of the findings and minimizing possible publication bias. In the quality assessment, a relatively low risk of bias was detected over most of the parameters assessed, supporting the reliability of the findings.
Regarding limitations, it is notable that although a relatively large number of diagnostic accuracy studies were identified (Cross, Hermens, Spencer, & Hickie, 2014) , split between different settings and scale iterations, each of the recommended cut-offs are based on only a small number of studies. In addition, the 14 identified studies were completed in 6 different countries, with the PQ translated into 5 different languages. Although all but one outlined a detailed translation procedure, suggesting high fidelity to the original scale, including a back-translation with the original author of the PQ (Loewy et al., 2005) , it is possible that both cultural and language differences may further limit the generalizability of the findings.
Another important consideration is that in 4 studies, a non-random selection of participants was followed up with the reference standard, resulting in possible partial verification bias. This artificially inflates sensitivity at the cost of specificity, so lower cut-offs than suggested may be needed in studies where verification bias may have occurred. Also, in a number of studies, the optimum thresholds for UHR screening were not presented, instead reporting the highest average of sensitivity and specificity. Finally, in one study , it was reported that some of the items of the PQ required modification to be appropriate for a Nigerian student population. Although it is likely that these changes would have improved the accuracy of the scale for this particular setting, changing the item content limits the generalizability of these findings to other populations.
Finally, as highlighted previously in the Methods section, it is important to note that these scales do not capture familial history of psychosis and schizotypal personality disorder nor are they designed to capture functional decline. As a result, in any screening programme, patients with GRDS without additional attenuated psychotic symptoms are unlikely to be identified. Although cases are typically rare, it should still be considered a significant issue as using this screening procedure alone may cause subgroups to be undetected and therefore not be able to access treatment. As a result, in screening procedures, it may be important to ask additional questions relating to familial history and functioning so as not to miss potentially eligible patients.
| Implications
Our results support the PQ as a tool to identify people who may meet criteria for UHR and propose guidelines as to what cut-off points may be the appropriate in different populations. One consistent finding was that higher cut-offs were required in samples with a lower prevalence of UHR and psychosis. However, in our review of the broader screening literature, symptom thresholds that have been validated in more enriched samples are commonly being adopted in less UHR-prevalent populations. In a non-help-seeking population, for example, a distress score of ≥9 may be the most appropriate for the PQ-16, a figure higher than the ≥6 used in all 3 identified studies conducted in this population (Chen et al., 2013; Suna, Wang, Shi, & Zhao, 2015; Wang et al., 2015) . Adopting thresholds appropriate for more enriched populations may increase false positives, reducing screening efficiency. Aside from resource considerations, this is problematic given the concerns regarding the possible impact of stigma of being identified as UHR (Yang, Wonpat-Borja, Opler, & Corcoran, 2010 ).
In the review of studies using the PQ as a screening tool, it was notable that a significant proportion was completed in non-helpseeking community samples (23 out of 45 studies). With the prevalence rate of psychotic-like experiences in the general population at approximately 5%, with 75% to 90% disappearing over time (van Os, Linscott, Myin-Germeys, Delespaul, & Krabbendam, 2009 ), screening such populations will likely result in a high false-positive rate. Furthermore, there have been recent concerns that applying UHR criteria to community samples not otherwise considered at risk may significantly weaken the diagnostic accuracy of the UHR paradigm (Fusar-Poli, 2017) . This has led to calls that UHR assessment should be limited to those both seeking help and exhibiting distress (Schultze-Lutter et al., 2015) . As a result, more caution should perhaps be exercised in using such screeners in community populations, particularly when measures of symptom distress are not being factored into the screening cut-off. However, with some evidence suggesting that many people who experience concerns regarding their mental health do not actively seek help prior to the onset of full psychotic symptoms (Addington, Van Mastrigt, Hutchinson, & Addington, 2002) , with factors such as stigma significantly impacting helpseeking behaviours (Clement et al., 2015) , there is also an argument that broader screening programmes may help identify people who might otherwise experience a delay in appropriate care.
To improve the early identification of psychosis, screening programs in schools and primary care settings have been proposed in the past (French, Owens, Parker & Dunn, 2012; Levitt, Saka, Romanelli, & Hoagwood, 2007) . However, no eligible studies validating the PQ in these settings were identified. In addition, the impact of other sociodemographic and psychopathological factors on screening effectiveness requires further consideration. For example, very young participants are more likely to report sub-threshold psychotic experiences, and this might be less associated with psychopathology (Brandizzi et al., 2014; Kelleher et al., 2012) . Although this may be the case, it was notable that 5 diagnostic accuracy studies had inclusion criteria allowing for participants to be as young as 12, whereas none reported any significant difficulties either in their comprehension of the scale or significantly higher scores relative to older participants. A future evaluation of the PQ and its diagnostic accuracy stratified across different ages may be helpful in determining both at what age the PQ is an effective screener of UHR and whether the effectiveness of different cut-off points are consistent between older and younger participants. In addition, it is unclear whether different thresholds may be appropriate for different cultures given that some of the items may be indicative of cultural differences rather than positive symptomology (Nuevo et al., 2010) . In future work, it would be helpful to determine whether particular PQ items are more predictive of a UHR diagnosis and to assess whether this is consistent between different populations. Finally, although there is much interest in a screening tool for full psychosis, to date, the PQ has not been fully evaluated for this purpose.
| CONCLUSIONS
This study further supports the use of the PQ as a screening tool to identify people with UHR presenting with attenuated psychotic symptoms. The findings suggest that higher cut-offs are required in lower UHR prevalence populations, whereas incorporating a measure of distress caused by symptoms may improve the accuracy of screening and minimize the rate of false positives. However, the impact of false positives and false negatives may be different depending on the requirements of the screening. In addition, further studies are required to replicate the presented findings. As a result, these recommendations should be considered a starting point in selecting which cut-off points to adopt in any future research or clinical practice.
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